AU3853800A - Pharmaceutical forms and methods for penetration continuity - Google Patents

Pharmaceutical forms and methods for penetration continuity

Info

Publication number
AU3853800A
AU3853800A AU38538/00A AU3853800A AU3853800A AU 3853800 A AU3853800 A AU 3853800A AU 38538/00 A AU38538/00 A AU 38538/00A AU 3853800 A AU3853800 A AU 3853800A AU 3853800 A AU3853800 A AU 3853800A
Authority
AU
Australia
Prior art keywords
methods
pharmaceutical forms
continuity
penetration
penetration continuity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38538/00A
Inventor
Ahmet Degirmenci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3853800A publication Critical patent/AU3853800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
AU38538/00A 1999-01-11 2000-01-11 Pharmaceutical forms and methods for penetration continuity Abandoned AU3853800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
TR9900033 1999-01-11
TR99/00033 1999-01-11
TR9903291 1999-12-28
TR99/03291 1999-12-28
PCT/TR2000/000001 WO2000041670A2 (en) 1999-01-11 2000-01-11 Pharmaceutical forms and methods for penetration continuity

Publications (1)

Publication Number Publication Date
AU3853800A true AU3853800A (en) 2000-08-01

Family

ID=26666345

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38538/00A Abandoned AU3853800A (en) 1999-01-11 2000-01-11 Pharmaceutical forms and methods for penetration continuity

Country Status (2)

Country Link
AU (1) AU3853800A (en)
WO (1) WO2000041670A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7880051B2 (en) 2003-11-28 2011-02-01 Coloplast A/S Dressing product
EP1784170B1 (en) 2004-09-01 2008-01-09 LABTEC GESELLSCHAFT FüR TECHNOLOGISCHE FORSCHUNG UND ENTWICKLUNG MBH Atrium patch
DE102005050654A1 (en) * 2005-10-20 2007-04-26 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH lip paving

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85083A1 (en) * 1983-11-09 1985-07-17 Oreal COSMETIC OR PHARMACEUTICAL COMPOSITION IN THE FORM OF A STICK OR STICK CONSISTING OF TWO CONCENTRIC FAT PHASES, ITS PREPARATION METHOD AND CASE FOR ALLOWING ITS STORAGE AND DISTRIBUTION
IT1287114B1 (en) * 1996-10-31 1998-08-04 Recordati Chem Pharm ANTI-HERPETIC PHARMACEUTICAL COMPOSITIONS FOR TOPICAL APPLICATORS, CONTAINING ACICLOVIR

Also Published As

Publication number Publication date
WO2000041670A3 (en) 2008-02-14
WO2000041670A2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
AU7101000A (en) Microfabrication methods and devices
AU6271401A (en) Drug administering system and administering method
AU2001253567A1 (en) System and method for projecting market penetration
AU6894700A (en) Therapeutic polypeptides and methods for using same
AU2373200A (en) Apparatuses and methods for forming assemblies
AU1632601A (en) System and method for pharmacy administration
AU3884701A (en) Cardiac methods and system
AU7989400A (en) Compounds and methods
AU2797499A (en) Tissue penetrating device and methods for using same
AU1160801A (en) Apparatus and method
AU3215500A (en) Compounds and methods
AU3543400A (en) Application apparatus and method
AU7484500A (en) Cargo-transfer apparatus and method
AU7065200A (en) Putting improvement devices and methods
AU5326100A (en) Pharmaceutical compositions and methods for use
AU715620C (en) Therapeutic methods and uses
AUPP855599A0 (en) Apparatus and method
AU5565099A (en) Pharmaceutical compositions and methods for use
AU5018000A (en) Displayer and method for displaying
AU5724000A (en) Anastomosis system and methods for use
AU7849200A (en) Mannosidases and methods for using same
AU7292300A (en) Synchronization method and synchronization arrangement
AU1083501A (en) Antibiotic-metal complex and methods
AU3853800A (en) Pharmaceutical forms and methods for penetration continuity
AU2570001A (en) Pharmaceutical composition and method for its manufacture